                               SEQUENCE LISTING

<110> THINK THERAPEUTICS

<120> MULTIPLEXED TESTING OF LYMPHOCYTES FOR ANTIGEN SPECIFICITY

<130> 2215269.00122WO1

<140>
<141>

<160> 9

<210> 1
<211> 115
<212> PRT
<213> Unknown

<220>
<223> VHH4

<400> 1
Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Gln Ala Gly Gly
1               5                   10                  15

Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Ser Thr Leu Ser Ser Tyr
            20                  25                  30

Gly Met Gly Trp Tyr Arg Gln Ala Pro Gly Lys Gln Arg Glu Val Val
        35                  40                  45

Ala Thr Ile Ser Ala Thr Gly Ser Ile Ser Tyr Ala Asp Ser Val Lys
    50                  55                  60

Gly Arg Phe Thr Ile Ser Arg Asp Ser Ala Lys Asn Thr Met Tyr Leu
65                  70                  75                  80

Gln Leu Asn Ser Leu Thr Pro Glu Asp Thr Ala Val Tyr Tyr Cys Asn
                85                  90                  95

Thr Ile Tyr Arg Ser Thr Leu Tyr Trp Gly Gln Gly Thr Gln Val Thr
            100                 105                 110

Val Ser Ser
        115

<210> 2
<211> 146
<212> PRT
<213> Unknown

<220>
<223> VHH7 protein sequence

<400> 2
Ala Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Ala Gly
1               5                   10                  15

Asp Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Arg Thr Phe Ser Arg
            20                  25                  30

Gly Val Met Gly Trp Phe Arg Arg Ala Pro Gly Lys Glu Arg Glu Phe
        35                  40                  45

Val Ala Ile Phe Ser Gly Ser Ser Trp Ser Gly Arg Ser Thr Tyr Tyr
    50                  55                  60

Ser Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys
65                  70                  75                  80

Asn Thr Val Tyr Leu Gln Met Asn Gly Leu Lys Pro Glu Asp Thr Ala
                85                  90                  95

Val Tyr Tyr Cys Ala Ala Gly Tyr Pro Glu Ala Tyr Ser Ala Tyr Gly
            100                 105                 110

Arg Glu Ser Thr Tyr Asp Tyr Trp Gly Gln Gly Thr Gln Val Thr Val
        115                 120                 125

Ser Ser Glu Pro Lys Thr Pro Lys Pro Gln Pro Ala Arg Gln Ala Cys
    130                 135                 140

Thr Ser
145

<210> 3
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic peptide

<400> 3
Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
1               5                   10

<210> 4
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic peptide

<220>
<223> Seed: LVVVGADGV (SEQ ID NO: 5)

<400> 4
Leu Met Val Val Gly Ala Asp Gly Val
1               5

<210> 5
<211> 9
<212> PRT
<213> Homo sapiens

<400> 5
Leu Val Val Val Gly Ala Asp Gly Val
1               5

<210> 6
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic peptide

<220>
<223> Seed: EYKLVVVGADGVG (SEQ ID NO: 7)

<400> 6
Glu Tyr Lys Phe Val Val Phe Gly Ser Asp Gly Ala Gly
1               5                   10

<210> 7
<211> 13
<212> PRT
<213> Homo sapiens

<400> 7
Glu Tyr Lys Leu Val Val Val Gly Ala Asp Gly Val Gly
1               5                   10

<210> 8
<211> 134
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic polypeptide

<400> 8
Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Gln Ala Gly Gly
1               5                   10                  15

Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Ser Thr Leu Ser Ser Tyr
            20                  25                  30

Gly Met Gly Trp Tyr Arg Gln Ala Pro Gly Lys Gln Arg Glu Val Val
        35                  40                  45

Ala Thr Ile Ser Ala Thr Gly Ser Ile Ser Tyr Ala Asp Ser Val Lys
    50                  55                  60

Gly Arg Phe Thr Ile Ser Arg Asp Ser Ala Lys Asn Thr Met Tyr Leu
65                  70                  75                  80

Gln Leu Asn Ser Leu Thr Pro Glu Asp Thr Ala Val Tyr Tyr Cys Asn
                85                  90                  95

Thr Ile Tyr Arg Ser Thr Leu Tyr Trp Gly Gln Gly Thr Gln Val Thr
            100                 105                 110

Val Ser Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Leu Met Val
        115                 120                 125

Val Gly Ala Asp Gly Val
    130

<210> 9
<211> 157
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic polypeptide

<400> 9
Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Gln Ala Gly Gly
1               5                   10                  15

Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Ser Thr Leu Ser Ser Tyr
            20                  25                  30

Gly Met Gly Trp Tyr Arg Gln Ala Pro Gly Lys Gln Arg Glu Val Val
        35                  40                  45

Ala Thr Ile Ser Ala Thr Gly Ser Ile Ser Tyr Ala Asp Ser Val Lys
    50                  55                  60

Gly Arg Phe Thr Ile Ser Arg Asp Ser Ala Lys Asn Thr Met Tyr Leu
65                  70                  75                  80

Gln Leu Asn Ser Leu Thr Pro Glu Asp Thr Ala Val Tyr Tyr Cys Asn
                85                  90                  95

Thr Ile Tyr Arg Ser Thr Leu Tyr Trp Gly Gln Gly Thr Gln Val Thr
            100                 105                 110

Val Ser Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Leu Met Val
        115                 120                 125

Val Gly Ala Asp Gly Val Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
    130                 135                 140

Glu Tyr Lys Phe Val Val Phe Gly Ser Asp Gly Ala Gly
145                 150                 155
